Media Summary: Join RMMSC Medical Director Dr. Timothy Vollmer for an in-depth look at disease modifying therapies (DMTs) – the front line in ... Dr. Timothy Vollmer gives an overview of the RMMSC's core treatment philosophy. The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in
Multiple Sclerosis Webinar A Deep - Detailed Analysis & Overview
Join RMMSC Medical Director Dr. Timothy Vollmer for an in-depth look at disease modifying therapies (DMTs) – the front line in ... Dr. Timothy Vollmer gives an overview of the RMMSC's core treatment philosophy. The FDA officially approved Ocrelizumab (brand name: Ocrevus) for use in Greg Tranah, Executive Director of Precision Medicine at Sutter Health, and Megan Laurance, Senior Director of Data Services at ... Associate Professor Yasmine Probst is IHMRI's leading researcher on the effects of nutrition on MS. Yasmine is living with MS ... Meeting Description: Have you recently been diagnosed with
Dr. Amanda Piquet's presentation focuses on the rapidly evolving field of Autoimmune Neurology. She defines antibody-mediated ... Recorded on March 1, 2022 Published Date: March 17, 2022 LISTEN with Guest Presenter: Aljoeson Walker, MD Neurology from ... Dr Wolfgang Marx is a researcher based a Deakin University. He will update us on the progress of his research into the effect of ... If you struggle to concentrate or have trouble with decision making, this video covers some of the most common thinking and ... This activity has been supported by sponsorship from Novartis Pharmaceuticals UK Limited. The sponsor has had no control over ... Transforming MS from Paper to practice - The solutions for paper-based
Neurological diseases are a big burden on society due to their largely chronic nature.
